GnRH analogue for chemotherapy-induced ovarian damage: too early to say?

Fertil Steril. 2009 Aug;92(2):e33; author reply e34. doi: 10.1016/j.fertnstert.2009.06.002.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / surgery
  • Adult
  • Amenorrhea / chemically induced
  • Amenorrhea / prevention & control
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / surgery
  • Estradiol / blood
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Follicle Stimulating Hormone, Human / blood
  • Gonadotropin-Releasing Hormone / agonists*
  • Goserelin / administration & dosage*
  • Humans
  • Infertility, Female / chemically induced
  • Infertility, Female / physiopathology
  • Infertility, Female / prevention & control*
  • Luteinizing Hormone / blood
  • Lymph Node Excision
  • Mastectomy
  • Menstruation / drug effects
  • Ovary / drug effects*
  • Ovary / physiopathology
  • Ovulation / drug effects
  • Primary Ovarian Insufficiency / chemically induced
  • Primary Ovarian Insufficiency / prevention & control

Substances

  • Fertility Agents, Female
  • Follicle Stimulating Hormone, Human
  • Goserelin
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Luteinizing Hormone